Hongjun Luo

Hongjun Luo

Auto-generated profile, based on publicly available information

Hongjun Luo

Bio-analytical Laboratory, Shantou University Medical College, Shantou, China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ZLZhexuan Lin
Zhexuan Lin
QZQuanwei Zhang
Quanwei Zhang
WLWenhong Luo
Wenhong Luo

4 January 2018 in Renal Failure
Verified
Journal Article
Open access
JSJinwan Shi
Jinwan Shi
JQJiuzhan Qian
Jiuzhan Qian
HLHui Li
Hui Li
WLWenhong Luo
Wenhong Luo
WLWenhong Luo
Wenhong Luo
ZLZhexuan Lin
Zhexuan Lin
Administration of mannitol with high dose could induce extensive isometric renal proximal tubular vacuolization and acute renal failure in clinic. We previously demonstrated that mannitol-induced human kidney tubular epithelial cell (HK-2) injury. The objective of our present work was to further study the cytotoxicity of mannitol in HK-2 cells and its potential mechanism. Cell viability was assessed by an MTT method. Cell morphological changes were observed. Furthermore, levels of malondialdehyde (MDA) and glutathione (GSH) were measured. Flow cytometry was performed to determine cell apoptosis by using Annexin V-FITC and PI. In addition, the F-actin of cells was labeled by FITC-Phalloidin for observation of cytoskeleton. The MTT assay displayed that the cell viability decreased significantly in a dose- and time-dependent manner. The morphological changes were observed, including cell membrane rapture and cell detachment. The GSH concentration in HK-2 cells decreased dramatically in mannitol treatment group, while MDA content increased significantly. The results of flow cytometry indicated that apoptotic percentages of HK-2 cells increased in 250 mmol/L mannitol treatment group. After treatment with 250 mmol/L mannitol for 48 h, HK-2 cells showed disorganization of cytoskeleton and even exhibited a totally destroyed cytoskeleton. Therefore, high dose of mannitol has a toxic effect on renal tubular epithelial cells, which might be attributed to oxidative stress, destroyed cellular cytoskeleton and subsequent cell apoptosis.


30 August 2024 in Circulation Research
Verified
Journal Article
Closed access
JGJiahui Ge
Jiahui Ge
YZYingbi Zhou
Yingbi Zhou
HLHui Li
Hui Li
RZRuhui Zeng
Ruhui Zeng
KXKaiqi Xie
Kaiqi Xie
BLBin zhou and Liu
Bin zhou and Liu
BACKGROUND: Prostaglandin I 2 synthesized by endothelial COX (cyclooxygenase) evokes potent vasodilation in some blood vessels but is paradoxically responsible for endothelium-dependent constriction (EDC) in others. Prostaglandin I 2 production and EDC may be enhanced in diseases such as hypertension. However, how PGIS (prostaglandin I 2 synthase) deficiency affects EDC and how this is implicated in the consequent cardiovascular pathologies remain largely unknown. METHODS: Experiments were performed with wild-type, Pgis knockout ( Pgis − / − ) and Pgis /thromboxane-prostanoid receptor gene ( Tp ) double knockout ( Pgis − / − Tp − / − ) mice and Pgis − / − mice transplanted with unfractionated wild-type or Cox-1 − / − bone marrow cells, as well as human umbilical arteries. COX-derived prostanoids were measured by high-performance liquid chromatography-mass spectrometry. Vasomotor responses of distinct types of arteries were assessed by isometric force measurement. Parameters of hypertension, vascular remodeling, and cardiac hypertrophy in mice at different ages were monitored. RESULTS: PGF 2α , PGE 2 , and a trace amount of PGD 2 , but not thromboxane A 2 (TxA 2 ), were produced in response to acetylcholine in Pgis − / − or PGIS-inhibited arteries. PGIS deficiency resulted in exacerbation or occurrence of EDC ex vivo and in vivo. Endothelium-dependent hyperpolarization was unchanged, but phosphorylation levels of eNOS (endothelial nitric oxide synthase) at Ser1177 and Thr495 were altered and NO production and the NO-dependent relaxation evoked by acetylcholine were remarkably reduced in Pgis − / − aortas. Pgis − / − mice developed high blood pressure and vascular remodeling at 16 to 17 weeks and subsequently cardiac hypertrophy at 24 to 26 weeks. Meanwhile, blood pressure and cardiac parameters remained normal at 8 to 10 weeks. Additional ablation of TP (TxA 2 receptor) not only restrained EDC and the downregulation of NO signaling in Pgis − / − mice but also ameliorated the cardiovascular abnormalities. Stimulation of Pgis − / − vessels with acetylcholine in the presence of platelets led to increased TxA 2 generation. COX-1 disruption in bone marrow–derived cells failed to affect the development of high blood pressure and vascular remodeling in Pgis − / − mice though it largely suppressed the increase of plasma TxB 2 (TxA 2 metabolite) level. CONCLUSIONS: Our study demonstrates that the non-TxA 2 prostanoids/TP axis plays an essential role in mediating the augmentation of EDC and cardiovascular disorders when PGIS is deficient, suggesting TP as a promising therapeutic target in diseases associated with PGIS insufficiency.

1 May 2013 in Cellular Immunology
Verified
Journal Article
Closed access
RLRui Li
Rui Li
HLHui Li
Hui Li
WLWenhong Luo
Wenhong Luo
ZLZhe-Xuan Lin
Zhe-Xuan Lin
ZJZhi-Wu Jiang
Zhi-Wu Jiang
WLWen-Hong Luo
Wen-Hong Luo